The evidence is somewhat thinner in the context of hematologic malignancies, however, CD1d has been shown to be expressed on multiple myeloma cells (159, 160), as well as AML cells (161) and iNKT exhibited reactivity to CD1d positive tumor cells in vitro in a α-GalCer–dependent manner. This evidence concerns the gene CD1D and hematologic disorder.